<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[TrakCel 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=37199></link><description><![CDATA[TrakCel 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Tue, 05 May 2026 09:54:20 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2021/03/12_3554238800_20210308115010_8758965606.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[TrakCel Fuels Growth and Increased Market Access Through Strategic Investment Round]]></title><link>https://www.newswire.co.kr/newsRead.php?no=919589</link><description><![CDATA[CARDIFF, Wales--(Business Wire/Korea Newswire)--TrakCel, a leading supplier of cellular orchestration solutions supporting the cell and gene therapy industry, today announces that it has closed its latest funding round led by AmerisourceBergen and Labcorp (NYSE: LH). These strategic investments enable further transformation of TrakCel’s cellular therapy orchestration solution, growth of its e...]]></description><pubDate>Mon, 08 Mar 2021 13:10:00 +0900</pubDate></item><item><title><![CDATA[트랙셀, 전략적 투자 라운드 통해 성장 및 시장 공략 강화]]></title><link>https://www.newswire.co.kr/newsRead.php?no=919590</link><description><![CDATA[카디프, 웨일즈--(Business Wire/뉴스와이어)--세포 및 유전자 치료 업계를 뒷받침하는 세포 오케스트레이션(cellular orchestration) 솔루션을 제공하는 선도적 기업 트랙셀(TrakCel)이 아메리소스버겐(AmerisourceBergen)과 랩코프(Labcorp)(뉴욕증권거래소: LH)가 주도한 최신 투자 라운드를 완료했다고 3일 발표했다.  이번 전략적 투자는 트랙셀이 세포 치료 오케스트레이션 솔루션을 혁신하고 기존 파트너 생태계 ...]]></description><pubDate>Mon, 08 Mar 2021 13:10:00 +0900</pubDate></item></channel></rss>